Covid: US backs waiver on vaccine patents to boost supply

Supporters say the move would increase vaccine production but the pharmaceutical industry disagrees.

This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.

Accept Learn more…